Related Experiment Videos
[Bone marrow transplantation in patients with leukemia]
Klinische Wochenschrift
|October 15, 1982
Summary
Bone marrow transplantation (BMT) showed successful engraftment in leukemia patients. Chronic graft-versus-host disease (GVHD) and infections were key challenges post-transplant.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Bone marrow transplantation (BMT) is a critical treatment for hematologic malignancies.
- Graft-versus-host disease (GVHD) and infections are significant post-transplant complications.
Purpose of the Study:
- To evaluate the efficacy and safety of BMT in leukemia patients.
- To assess the impact of antihuman T-cell globulin (AHTCG) on GVHD prophylaxis.
Main Methods:
- Conducted BMT on 20 leukemia patients between 1979 and 1982.
- Used a conditioning regimen of cyclophosphamide and whole-body irradiation.
- Administered AHTCG-preincubated donor marrow in 15 patients for GVHD prophylaxis.
Main Results:
- Achieved prompt engraftment and complete chimerism in all patients.
- Observed 12/20 patient survival between 25 and 900 days.
- Reported severe GVHD in two patients, one receiving AHTCG, and significant chronic GVHD and infections.
Conclusions:
- BMT can lead to successful engraftment and chimerism in leukemia.
- While acute GVHD was manageable, chronic GVHD and late infectious complications like interstitial pneumonia remain major challenges.